Search Results - "Sikes, R A"

Refine Results
  1. 1

    Osteopontin: Possible Role in Prostate Cancer Progression by Thalmann, G N, Sikes, R A, Devoll, R E, Kiefer, J A, Markwalder, R, Klima, I, Farach-Carson, C M, Studer, U E, Chung, L W

    Published in Clinical cancer research (01-08-1999)
    “…Human prostate cancer has the propensity to metastasize to the bone where reciprocal cellular interactions between prostate cancer and bone cells are known to…”
    Get full text
    Journal Article
  2. 2

    LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis by Thalmann, George N., Sikes, Robert A., Wu, Tony T., Degeorges, Armelle, Chang, Shi-Ming, Ozen, Mustafa, Pathak, Sen, Chung, Leland W.K.

    Published in The Prostate (01-07-2000)
    “…BACKGROUND Clinically, the lethal phenotypes of human prostate cancer are characterized by their progression to androgen‐independence and their propensity to…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Suramin-Induced Decrease in Prostate-Specific Antigen Expression With No Effect on Tumor Growth in the LNCaP Model of Human Prostate Cancer by Thalmann, George N., Sikes, Robert A., Chang, Shi-Ming, Johnston, Dennis A., von Eschenbach, Andrew C., Chung, Leland W. K.

    “…Background: Suramin, a polysulfonated naphthylurea and a recognized antitrypanosomal agent, has shown some promise in phase II clinical trials in the…”
    Get full text
    Journal Article
  5. 5

    Osteocalcin promoter-based toxic gene therapy for the treatment of osteosarcoma in experimental models by KO, S.-C, CHEON, J, KAO, C, GOTOH, A, SHIRAKAWA, T, SIKES, R. A, KARSENTY, G, CHUNG, L. W. K

    Published in Cancer research (Chicago, Ill.) (15-10-1996)
    “…Osteocalcin (OC), a noncollagenous bone matrix protein, is expressed in high levels by osteoblasts. To determine whether the OC promoter mediates cell-specific…”
    Get full text
    Journal Article
  6. 6

    The accuracy of selective magnetic resonance imaging compared with the findings of arthroscopy of the knee by Polly, D W, Callaghan, J J, Sikes, R A, McCabe, J M, McMahon, K, Savory, C G

    “…The results of selective magnetic resonance imaging of the knee were compared with those of arthroscopy in a prospective series of fifty patients. A…”
    Get full text
    Journal Article
  7. 7

    Human prostate cancer expresses the low affinity insulin-like growth factor binding protein IGFBP-rP1 by DEGEORGES, A, FUAN WANG, FRIERSON, H. F, SETH, A, CHUNG, L. W. K, SIKES, R. A

    Published in Cancer research (Chicago, Ill.) (15-06-1999)
    “…Many of the alterations in the insulin-like growth factor (IGF) axis in prostatic disease have been associated with changes in the insulin-like growth factor…”
    Get full text
    Journal Article
  8. 8

    Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer by Hyytinen, Eija-Riitta, Frierson Jr, Henry F., Sipe, Tavis W., Li, Chang-Ling, Degeorges, Armelle, Sikes, Robert A., Chung, Leland W.K., Dong, Jin-Tang

    Published in The Prostate (01-11-1999)
    “…BACKGROUND Three regions of chromosome 13 were previously identified for having loss of heterozygosity (LOH) in human prostate cancer. One of them, at 13q33,…”
    Get full text
    Journal Article
  9. 9

    Transfected neu oncogene induces human prostate cancer metastasis by Zhau, Haiyen Y. E., Zhou, Jianxin, Symmans, W. Fraser, Chen, Bao-Qi, Chang, Shi-Ming, Sikes, Robert A., Chung, Leland W. K.

    Published in The Prostate (01-02-1996)
    “…c‐erb B2/neu has been demonstrated to be a transforming oncogene in both rodent and human prostatic epithelial cells. To understand the potential role of neu…”
    Get full text
    Journal Article
  10. 10

    Isolation and characterization of PAGE-1 and GAGE-7. New genes expressed in the LNCaP prostate cancer progression model that share homology with melanoma-associated antigens by Chen, M E, Lin, S H, Chung, L W, Sikes, R A

    Published in The Journal of biological chemistry (10-07-1998)
    “…The LNCaP progression model of human prostate cancer consists of lineage-related sublines that differ in their androgen sensitivity and metastatic potential. A…”
    Get full text
    Journal Article
  11. 11

    Distribution of IGFBP-rP1 in Normal Human Tissues by Degeorges, Armelle, Wang, Fuan, Frierson, Henry F., , Jr, Seth, Arun, Sikes, Robert A

    “…IGFBP-rP1/mac25 is a recently described member of the insulin-like growth factor binding protein (IGFBP) family. It has structural homology to the other…”
    Get full text
    Journal Article
  12. 12

    A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans by Cleutjens, K B, van der Korput, H A, Ehren-van Eekelen, C C, Sikes, R A, Fasciana, C, Chung, L W, Trapman, J

    Published in Molecular endocrinology (Baltimore, Md.) (01-08-1997)
    “…Prostate-specific antigen (PSA) is a kallikrein-like serine protease, which is almost exclusively synthesized in the luminal epithelial cells of the human…”
    Get full text
    Journal Article
  13. 13

    Inhibition of experimentally induced mouse prostatic hyperplasia by castration or steroid antagonist administration by Sikes, R A, Thomsen, S, Petrow, V, Neubauer, B L, Chung, L W

    Published in Biology of reproduction (01-08-1990)
    “…Mouse prostatic hyperplasia has been induced experimentally by implanting fetal urogenital sinus tissue into the prostate gland of syngeneic mice. We compared…”
    Get full text
    Journal Article
  14. 14

    Photodynamic therapy with photofrin II induces programmed cell death in carcinoma cell lines by He, X Y, Sikes, R A, Thomsen, S, Chung, L W, Jacques, S L

    Published in Photochemistry and photobiology (01-04-1994)
    “…The mode of cell death following photodynamic therapy was investigated from the perspective of programmed cell death or apoptosis. Human prostate carcinoma…”
    Get more information
    Journal Article
  15. 15

    Molecular determination of surgical margins using fossa biopsies at radical prostatectomy by Theodorescu, D, Frierson, Jr, H F, Sikes, R A

    Published in The Journal of urology (01-05-1999)
    “…Status of the surgical margins after radical prostatectomy is a key factor for predicting postoperative outcome. Current methods used to determine margin…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Integrin expression and usage by prostate cancer cell lines on laminin substrata by EDLUND, Magnus, MIYAMOTO, Tadayuki, SIKES, Robert A, OGLE, Roy, LAURIE, Gordon W, FARACH-CARSON, Mary C, OTEY, Carol A, ZHAU, Haiyen E, CHUNG, Leland W. K

    Published in Cell growth & differentiation (01-02-2001)
    “…During prostate cancer progression, invasive glandular epithelial cells move out of the ductal-acinar architecture and through the surrounding basement…”
    Get full text
    Journal Article
  18. 18

    Comparison of the Deduced Amino Acid Sequence of Guinea Pig Adenovirus Hexon Protein with That of Other Mastadenoviruses by Feldman, Sanford H., Sikes, Robert A., Eckhoff, Gary A.

    Published in Comparative medicine (01-04-2001)
    “…Purpose: We sought to isolate, clone, and determine the nucleic acid sequence of the guinea pig adenovirus (GPAdV) hexon gene. From this, the amino acid…”
    Get full text
    Journal Article
  19. 19

    Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene by Sikes, R A, Chung, L W

    Published in Cancer research (Chicago, Ill.) (01-06-1992)
    “…The neu oncogene has been demonstrated to be a potent transforming gene in rodent fibroblasts. The overexpression of the human erbB-2/neu oncogene has been…”
    Get full text
    Journal Article
  20. 20

    Abstract P2-09-20: 2’(3’)-O-(4-benzoylbenzoyl)adenosine 5’-triphosphate (BzATP) is a potential drug for triple negative breast cancer: Autophagy and apoptosis inducer by Lertsuwan, J, Sikes, RA

    Published in Cancer research (Chicago, Ill.) (15-12-2013)
    “…Triple-negative breast cancer (TNBC) is among the most aggressive and therapy resistant type of breast cancer. New therapeutic strategies and new treatments…”
    Get full text
    Journal Article